Preeclampsia screening study for pregnant women
Part of Women’s health & pregnancy clinical trials.
This study collects blood samples and routine pregnancy data to improve early detection of preeclampsia (a serious pregnancy complication). It aims to build a biobank for future research, and you can participate if you are in your first trimester with a single baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and pregnant with one baby.
- You are between 11 and 14 weeks pregnant.
- You agree to give blood samples (up to 25 mL) at each trimester visit.
- You agree to let the study team look at your routine prenatal test results.
- You are not in a blinded aspirin study and you know your aspirin dose.
- You are willing to share your pregnancy and baby health information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to see if a new blood test can help predict preeclampsia, a serious condition that can occur during pregnancy. It may help identify risk early so that you and your baby can receive the right care.
This trial studies whether extra screening in the first trimester for preeclampsia (dangerous blood pressure problems in pregnancy) can reduce health problems for both the mother and baby. You may be offered a screening plan that helps identify risk earlier so care can be adjusted.
This research study follows pregnant people with preeclampsia (a serious blood-pressure condition in pregnancy) to understand how it develops and affects both mother and baby. By participating, you help doctors learn more about this condition and potentially improve care for future patients.
This study looks for proteins in the blood that may show early signs of heart stress in pregnant women with preeclampsia, before symptoms appear. It also uses heart ultrasound to see how the heart changes during pregnancy, which could help find women at risk earlier.
This study offers a combined screening test for pregnant women in their first trimester. It helps check for potential health issues early in pregnancy.
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
Hear when a new Preeclampsia (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.